Chartwell Investment Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Chartwell Investment Partners’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-91,490	Closed	-$1.46M	–	434
2021 Q4	$1.46M	Buy	91,490 +25,311	+38%	+$394K	0.04%	350
2021 Q3	$1.32M	Hold	66,179	–	–	0.04%	351
2021 Q2	$1.14M	Buy	66,179 +595	+0.9%	+$10.7K	0.03%	362
2021 Q1	$1.3M	Sell	65,584 -3,524	-5%	-$67.5K	0.04%	343
2020 Q4	$1.21M	Buy	69,108 +23,625	+52%	+$464K	0.04%	345
2020 Q3	$876K	Buy	45,483 +28,373	+166%	+$609K	0.03%	359
2020 Q2	$333K	Buy	+17,110	New	+$286K	0.01%	392

Other funds holding MIRM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chartwell Investment Partners's MIRM Position: Q1 2022 in Review

Chartwell Investment Partners sold out of Mirum Pharmaceuticals (MIRM) in Q1 2022, closing a stake of 91,490 shares — an estimated $1.46M sold.

Chartwell Investment Partners first reported a position in MIRM in Q2 2020 and held it in 7 quarters. The position peaked at $1.46M in Q4 2021. 99 funds tracked by Wall St. Rank hold MIRM as of Q1 2022.

Chartwell Investment Partners reported no remaining Mirum Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Chartwell Investment Partners sold 91,490 Mirum Pharmaceuticals shares in Q1 2022, an estimated $1.46M.
Chartwell Investment Partners first reported a position in Mirum Pharmaceuticals in Q2 2020 and held it in 7 quarters.
Chartwell Investment Partners's Mirum Pharmaceuticals position peaked at $1.46M in Q4 2021.
99 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2022.

Based on Chartwell Investment Partners's 13F filing for Q1 2022, filed 26 Apr 2022.